Literature DB >> 31116466

Aortopulmonary window in adults: A rare entity leading to Eisenmenger syndrome.

Joud El Dick1, Issam El-Rassi2, Christelle Tayeh3, Fadi Bitar3, Mariam Arabi3.   

Abstract

An aortopulmonary window (APW) is a rare congenital heart defect involving an abnormal communication between the ascending aorta and the pulmonary trunk with separate aortic and pulmonary valves. This defect accounts for 0.2% of all congenital cardiac anomalies and if left untreated can lead to Eisenmenger syndrome, severe pulmonary hypertension, heart failure, and poor survival. The authors herein present a case of APW type III with Eisenmenger syndrome in an adult patient whose initial complaint was cyanosis, and provide a thorough review of the literature of cases of APW with Eisenmenger syndrome that have survived into adulthood.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  2D echocardiography; cardiac imaging; color Doppler; congenital heart defects; congenital heart disease

Mesh:

Year:  2019        PMID: 31116466     DOI: 10.1111/echo.14368

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  3 in total

1.  Late presentation of aortopulmonary window: a contemporary series.

Authors:  Debasis Das; Nilanjan Dutta; Patralekha Das; Manish Kumar Sharma; Rangan Koley; Shubhadeep Das; Amitabha Chattopadhyay; Sanjiban Ghosh; Pradeep Narayan
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2022-01-08

2.  Aortopulmonary window: Types, associated cardiovascular anomalies, and surgical outcome. Retrospective analysis of a single center experience.

Authors:  Mohammed Bin-Moallim; Hussam K Hamadah; Fahad Alhabshan; Abdullah A Alghamdi; Mohamed S Kabbani
Journal:  J Saudi Heart Assoc       Date:  2020-05-10

3.  A Rare Case of Adult Aortopulmonary Window Combined with Anomalous Origin of the Right Pulmonary Artery from the Aorta Leading to Eisenmenger Syndrome.

Authors:  Mingyue Cui; Binfeng Xia; Heru Wang; Haihui Liu; Xia Yin
Journal:  J Int Med Res       Date:  2021-01       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.